Saeed Motahari, President & CEO at Insys Therapeutics, Inc. (INSY), bought 5,500 shares at $8.92 ($49K) on 2017-08-10, disclosed to the SEC on 2017-08-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |